Onco-nephrology: Glomerular diseases with cancer

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 10, 2012, Pages 1701-1712

  Cambier, Jean François ^a   Ronco, Pierre ^a,b,c  

^a HÔPITAL TENON   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BORTEZOMIB; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER REGRESSION; CARCINOMA; CHRONIC LYMPHATIC LEUKEMIA; DISEASE ASSOCIATION; DRUG FATALITY; GLOMERULOPATHY; HODGKIN DISEASE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; MEMBRANOUS GLOMERULONEPHRITIS; MYELOMA; MYELOPROLIFERATIVE DISORDER; NEOPLASM; PARANEOPLASTIC SYNDROME; PLASMA CELL DYSCRASIA; PREVALENCE; PROLIFERATIVE GLOMERULONEPHRITIS; SOLID TUMOR; WALDENSTROEM MACROGLOBULINEMIA;

EID: 84867253319     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03770412     Document Type: Article

References (97)

1. Puolijoki H, Mustonen J, Pettersson E, Pasternack A, Lahdensuo A: Proteinuria and haematuria are frequently present in patients with lung cancer. Nephrol Dial Transplant 4: 947-950, 1989
2. Sawyer N, Wadsworth J, Wijnen M, Gabriel R: Prevalence, concentration, and prognostic importance of proteinuria in patients with malignancies. Br Med J (Clin Res Ed) 296: 1295-1298, 1988
3. Lee JC, Yamauchi H, Hopper J Jr: The association of cancer and the nephrotic syndrome. Ann Intern Med 64: 41-51, 1966
4. Birkeland SA, Storm HH: Glomerulonephritis and malignancy: A population-based analysis. Kidney Int 63: 716-721, 2003
5. Jørgensen L, Heuch I, Jenssen T, Jacobsen BK: Association of albuminuria and cancer incidence. J Am Soc Nephrol 19: 992-998, 2008
6. Glassock RJ: The pathogenesis of idiopathic membranous nephropathy: A 50-year odyssey. Am J Kidney Dis 56: 157-167, 2010
7. Burstein DM, Korbet SM, Schwartz MM: Membranous glomerulonephritis and malignancy. Am J Kidney Dis 22: 5-10, 1993
8. Lefaucheur C, Stengel B, Nochy D, Martel P, Hill GS, Jacquot C, Rossert J; GN-PROGRESS Study Group: Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int 70: 1510-1517, 2006
9. Alpers CE, Cotran RS: Neoplasia and glomerular injury. Kidney Int 30: 465-473, 1986
10. Bacchetta J, Juillard L, Cochat P, Droz JP: Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol 70: 39-58, 2009
11. Ronco PM: Paraneoplastic glomerulopathies: New insights into an old entity. Kidney Int 56: 355-377, 1999
12. Eagen JW: Glomerulopathies of neoplasia. Kidney Int 11: 297-303, 1977
13. Bjørneklett R, Vikse BE, Svarstad E, Aasarød K, Bostad L, Langmark F, Iversen BM: Long-term risk of cancer in membranous nephropathy patients. Am J Kidney Dis 50: 396-403, 2007
14. Beck LH Jr: Membranous nephropathy and malignancy. Semin Nephrol 30: 635-644, 2010
15. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009
16. Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, Helmchen U, Stahl RA: An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 26: 2526-2532, 2011
17. Ronco P, Debiec H: Pathogenesis of membranous nephropathy: Recent advances and future challenges. Nat Rev Nephrol 8: 203-213, 2012
18. Debiec H, Ronco P: Nephrotic syndrome: A new specific test for idiopathic membranous nephropathy. Nat Rev Nephrol 7: 496-498, 2011
19. Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z: Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22: 1137-1143, 2011
20. Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, Kigawa A, Sawada K, Imai H: Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant 19: 574-579, 2004
21. Qu Z, Liu G, Li J, Wu LH, Tan Y, Zheng X, Ao J, Zhao MH: Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. Nephrol Dial Transplant 27: 1931-1937, 2012
22. Mustonen J, Pasternack A, Helin H: IgA mesangial nephropathy in neoplastic diseases. Contrib Nephrol 40: 283-291, 1984
23. Magyarlaki T, Kiss B, Buzogány I, Fazekas A, Sükösd F, Nagy J: Renal cell carcinoma and paraneoplastic IgA nephropathy. Nephron 82: 127-130, 1999
24. Pankhurst T, Savage CO, Gordon C, Harper L: Malignancy is increased in ANCA-associated vasculitis. Rheumatology (Oxford) 43: 1532-1535, 2004
25. Pertuiset E, Lioté F, Launay-Russ E, Kemiche F, Cerf-Payrastre I, Chesneau AM: Adult Henoch-Schonlein purpura associated with malignancy. Semin Arthritis Rheum 29: 360-367, 2000
26. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D: Henoch-Schönlein Purpura in adults: Outcome and prognostic factors. J Am Soc Nephrol 13: 1271-1278, 2002
27. Whitworth JA, Morel-Maroger L, Mignon F, Richet G: The significance of extracapillary proliferation. Clinicopathological review of 60 patients. Nephron 16: 1-19, 1976
28. Biava CG, Gonwa TA, Naughton JL, Hopper J Jr: Crescentic glomerulonephritis associated with nonrenalmalignancies. Am J Nephrol 4: 208-214, 1984
29. Tatsis E, Reinhold-Keller E, Steindorf K, Feller AC, Gross WL: Wegener's granulomatosis associated with renal cell carcinoma. Arthritis Rheum 42: 751-756, 1999
30. Vanatta PR, Silva FG, Taylor WE, Costa JC: Renal cell carcinoma and systemic amyloidosis: demonstration of AA protein and review of the literature. Hum Pathol 14: 195-201, 1983
31. Glassock RJ: Secondary minimal change disease. Nephrol Dial Transplant 18[Suppl 6]: vi52-vi58, 2003
32. Karras A, de Montpreville V, Fakhouri F, Grunfeld JP, Lesavre P; Groupe d'Etudes des Néphropathies Associées aux Thymomes: Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature. Nephrol Dial Transplant 20: 1075-1082, 2005
33. Plager J, Stutzman L: Acute nephrotic syndrome as a manifestation of activeHodgkin's Disease. Report of four cases and review of the literature. Am J Med 50: 56-66, 1971
34. Kramer P, Sizoo W, Twiss EE: Nephrotic syndrome in Hodgkin's disease. Report of five cases and review of the literature. Neth J Med 24: 114-119, 1981
35. Franklin EC, Pras M, Levin M, Frangione B: The partial amino acid sequence of the major low molecular weight component of two human amyloid fibrils. FEBS Lett 22: 121-123, 1972
36. Audard V, Larousserie F, Grimbert P, Abtahi M, Sotto JJ, Delmer A, Boue F, Nochy D, Brousse N, Delarue R, Remy P, Ronco P, Sahali D, Lang P, Hermine O: Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: Report of 21 cases and review of the literature. Kidney Int 69: 2251-2260, 2006
37. Moorthy AV, Zimmerman SW, Burkholder PM: Nephrotic syndrome in Hodgkin's disease. Evidence for pathogenesis alternative to immune complex deposition. Am J Med 61: 471-477, 1976
38. Shalhoub RJ: Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2: 556-560, 1974
39. Grimbert P, Valanciute A, Audard V, Pawlak A, Le gouvelo S, Lang P, Niaudet P, Bensman A, Guellaën G, Sahali D: Truncation of Cmip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization. J Exp Med 198: 797-807, 2003
40. Zhang SY, Kamal M, Dahan K, Pawlak A, Ory V, Desvaux D, Audard V, Candelier M, BenMohamed F, Matignon M, Christov C, Decrouy X, Bernard V, Mangiapan G, Lang P, Guellaën G, Ronco P, Sahali D: C-mip impairs podocyte proximal signaling and induces heavy proteinuria. Sci Signal 3: ra39, 2010
41. Audard V, Zhang SY, Copie-Bergman C, Rucker-Martin C, Ory V, Candelier M, Baia M, Lang P, Pawlak A, Sahali D: Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip inHodgkin-Reed Sternberg cells and podocytes. Blood 115: 3756-3762, 2010
42. Bergmann J, Buchheidt D, Waldherr R, Maywald O, van der Woude FJ, Hehlmann R, Braun C: IgA nephropathy and Hodgkin's disease: A rare coincidence. Case report and literature review. Am J Kidney Dis 45: e16-e19, 2005
43. Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, Drew R: Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 47: 673-680, 2001
44. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA: Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: Relative sensitivity for detection of monoclonal light chains. Clin Chem 48: 1437-1444, 2002
45. Scott RB: Leukaemia. Lancet 272: 1162-1167, 1957
46. Seney FD Jr, Federgreen WR, Stein H, Kashgarian M: A review of nephrotic syndrome associated with chronic lymphocytic leukemia. Arch Intern Med 146: 137-141, 1986
47. Moulin B, Ronco PM, Mougenot B, François A, Fillastre JP, Mignon F: Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int 42: 127-135, 1992
48. Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, Stokes MB, Nadasdy T, D'Agati VD: Proliferative glomerulonephritis with monoclonal IgG deposits. J AmSoc Nephrol 20: 2055-2064, 2009
49. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M: Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57: 775-788, 1974
50. Randall RE, Williamson WC Jr, Mullinax F, Tung MY, Still WJ: Manifestations of systemic light chain deposition. Am J Med 60: 293-299, 1976
51. Bridoux F, Hugue V, Coldefy O, Goujon JM, Bauwens M, Sechet A, Preud'Homme JL, Touchard G: Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int 62: 1764-1775, 2002
52. Nasr SH, Markowitz GS, Stokes MB, Seshan SV, Valderrama E, Appel GB, Aucouturier P, D'Agati VD: Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis. Kidney Int 65: 85-96, 2004
53. Guiard E, Karras A, Plaisier E, Duong Van Huyen JP, Fakhouri F, Rougier JP, Noel LH, Callard P, Delahousse M, Ronco P: Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: Correlation with IgG subclass and response to rituximab. Clin J Am Soc Nephrol 6: 1609-1616, 2011
54. Sethi S, Zand L, Leung N, Smith RJH, Jevremonic D, Herrmann SS, Fervenza FC: Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol 5: 770-782, 2010
55. Morel-Maroger L, Basch A, Danon F, Verroust P, Richet G: Pathology of the kidney in Waldenström's macroglobulinemia. Study of sixteen cases. N Engl J Med 283: 123-129, 1970
56. Da'as N, Kleinman Y, Polliack A, Amir G, Ne'eman Z, Kopolovic J, Bits H, Darmon D: Immunotactoid glomerulopathy with massive bone marrow deposits in a patient with IgM kappa monoclonal gammopathy and hypocomplementemia. AmJ KidneyDis 38: 395-399, 2001
57. Dussol B, Kaplanski G, Daniel L, Brunet P, Pellissier JF, Berland Y: Simultaneous occurrence of fibrillary glomerulopathy and AL amyloid. Nephrol Dial Transplant 13: 2630-2632, 1998
58. Tomiyoshi Y, Sakemi T, Yoshikawa Y, Shimokama T, Watanabe T: Fibrillar crystal structure in essential monoclonal IgM kappa cryoglobulinemia. Clin Nephrol 49: 325-327, 1998
59. Meyrier A, Simon P, Mignon F, Striker L, Ramée MP: Rapidly progressive ('crescentic') glomerulonephritis and monoclonal gammapathies. Nephron 38: 156-162, 1984
60. Garcia-Pacheco I, Khan A, Venkat KK: Rapidly progressive glomerulonephritis in a patient with Waldenström's macroglobulinemia. Clin Nephrol 64: 396-399, 2005
61. Nakamoto Y, Imai H, Hamanaka S, Yoshida K, Akihama T, Miura AB: IgM monoclonal gammopathy accompanied by nodular glomerulosclerosis, urine-concentrating defect, and hyporeninemic hypoaldosteronism. Am J Nephrol 5: 53-58, 1985
62. Audard V, Georges B, Vanhille P, Toly C, Deroure B, Fakhouri F, Cuvelier R, Belenfant X, Surin B, Aucouturier P, Mougenot B, Ronco P: Renal lesions associated with IgM-secreting monoclonal proliferations: Revisiting the disease spectrum. Clin J Am Soc Nephrol 3: 1339-1349, 2008
63. Glenner GG, Terry W, Harada M, Isersky C, Page D: Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses. Science 172: 1150-1151, 1971
64. Iványi B: Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 114: 986-987, 1990
65. Herrera GA, Joseph L, Gu X, Hough A, Barlogie B: Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch Pathol Lab Med 128: 875-879, 2004
66. Ronco P, Plaisier E, Mougenot B, Aucouturier P: Immunoglobulin light (heavy)-chain deposition disease: From molecularmedicine to pathophysiology-driven therapy. Clin J Am Soc Nephrol 1: 1342-1350, 2006
67. Ganeval D, Noel LH, Preud'homme JL, Droz D, Grünfeld JP: Light-chain deposition disease: Its relation with AL-type amyloidosis. Kidney Int 26: 1-9, 1984
68. Went P, Ascani S, Strøm E, Brorson SH, Musso M, Zinzani PL, Falini B, Dirnhofer S, Pileri S: Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease. Lancet Oncol 5: 381-383, 2004
69. Teng J, Russell WJ, Gu X, Cardelli J, Jones ML, Herrera GA: Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns. Lab Invest 84: 440-451, 2004
70. Keeling J, Herrera GA: Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage. Kidney Int 68: 1590-1603, 2005
71. Ronco PM, Alyanakian MA, Mougenot B, Aucouturier P: Light chain deposition disease: A model of glomerulosclerosis defined at the molecular level. J Am Soc Nephrol 12: 1558-1565, 2001
72. Droz D, Noel LH, Carnot F, Degos F, Ganeval D, Grunfeld JP: Liver involvement in nonamyloid light chain deposits disease. Lab Invest 50: 683-689, 1984
73. Buxbaum JN, Chuba JV, Hellman GC, Solomon A, Gallo GR: Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med 112: 455-464, 1990
74. Heilman RL, Velosa JA, Holley KE, Offord KP, Kyle RA: Long-term follow-up and response to chemotherapy in patients with lightchain deposition disease. Am J Kidney Dis 20: 34-41, 1992
75. Kambham N, Markowitz GS, Appel GB, Kleiner MJ, Aucouturier P, D'agati VD: Heavy chain deposition disease: The disease spectrum. Am J Kidney Dis 33: 954-962, 1999
76. Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, D'Agati VD: Renal monoclonal immunoglobulin deposition disease: The disease spectrum. J Am Soc Nephrol 12: 1482-1492, 2001
77. Masai R, Wakui H, Togashi M, Maki N, Ohtani H, Komatsuda A, Sawada K: Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease. Clin Nephrol 71: 9-20, 2009
78. Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, D'Agati VD, Leung N: Renal monoclonal immunoglobulin deposition disease: A report of 64 patients from a single institution. Clin J Am Soc Nephrol 7: 231-239, 2012
79. Aucouturier P, Khamlichi AA, Touchard G, Justrabo E, Cogne M, Chauffert B, Martin F, Preud'homme JL: Brief report: Heavy-chain deposition disease. N Engl J Med 329: 1389-1393, 1993
80. Katz A, Zent R, Bargman JM: IgGheavy-chain deposition disease. Mod Pathol 7: 874-878, 1994
81. Yasuda T, Fujita K, Imai H, Morita K, Nakamoto Y, Miura AB: Gamma-heavy chain deposition disease showing nodular glomerulosclerosis. Clin Nephrol 44: 394-399, 1995
82. Herzenberg AM, Lien J, Magil AB: Monoclonal heavy chain (immunoglobulin G3) deposition disease: Report of a case. Am J Kidney Dis 28: 128-131, 1996
83. Cheng IK, Ho SK, Chan DT, Ng WK, Chan KW: Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin alpha heavy chain deposition. Am J Kidney Dis 28: 283-288, 1996
84. Husby G, Blichfeldt P, Brinch L, Brandtzaeg P, Mellbye OJ, Sletten K, Stenstad T: Chronic arthritis and g heavy chain disease: Coincidence or pathogenic link? Scand J Rheumatol 27: 257-264, 1998
85. Rott T, Vizjak A, Lindic J, Hvala A, Perkovic T, Cernelc P: IgG heavy-chain deposition disease affecting kidney, skin, and skeletal muscle. Nephrol Dial Transplant 13: 1825-1828, 1998
86. Polski JM, Galvin N, Salinas-Madrigal L: Non-amyloid fibrils in heavy chain deposition disease. Kidney Int 56: 1601-1602, 1999
87. Moulin B, Deret S, Mariette X, Kourilsky O, Imai H, Dupouet L, Marcellin L, Kolb I, Aucouturier P, Brouet JC, Ronco PM, Mougenot B: Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1. J AmSoc Nephrol 10: 519-528, 1999
88. Liapis H, Papadakis I, Nakopoulou L: Nodular glomerulosclerosis secondary to m heavy chain deposits. Hum Pathol 31: 122-125, 2000
89. Vedder AC, Weening JJ, Krediet RT: Intracapillary proliferative glomerulonephritis due to heavy chain deposition disease. Nephrol Dial Transplant 19: 1302-1304, 2004
90. Soma J, Sato K, Sakuma T, Saito H, Sato H, Sato T, Abbas A, Aucouturier P: Immunoglobulin gamma3-heavy-chain deposition disease: Report of a case and relationship with hypocomplementemia. Am J Kidney Dis 43: E10-E16, 2004
91. Soma J, Tsuchiya Y, Sakuma T, Sato H: Clinical remission and histopathological resolution of nodular lesions in a patient with gamma3 heavy-chain deposition disease. Clin Nephrol 69: 383-386, 2008
92. Oe Y, Nakaya I, Yahata M, Sakuma T, Sato H, Soma J: A case of g1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy. Intern Med 49: 1411-1415, 2010
93. Ronco P, Plaisier E, Aucouturier P: Ig-related renal disease in lymphoplasmacytic disorders: An update. Semin Nephrol 30: 557-569, 2010
94. Ronco P, Bridoux F, Aucouturier P: Monoclonal gammopathies: Multiple myeloma, amyloidosis, and related disorders. In: Diseases of the Kidney, edited by Neilson EG, Molitoris B, Coffman T, Falk R, and Schrier RW, 9th Ed., Philadelphia, LippincottWilliams &Wilkins, 2012, in press
95. Sanchorawala V: Light-chain (AL) amyloidosis: Diagnosis and treatment. Clin J Am Soc Nephrol 1: 1331-1341, 2006
96. Au WY, Chan KW, Lui SL, Lam CC, Kwong YL: Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders. Am J Kidney Dis 34: 889-893, 1999
97. Said SM, Leung N, Sethi S, Cornell LD, Fidler ME, Grande JP, Herrmann S, Tefferi A, D'Agati VD, Nasr SH: Myeloproliferative neoplasms cause glomerulopathy. Kidney Int 80: 753-759, 2011